Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Knock yourself out. With this POS that rule does not apply.
Buy Weakness Sell Strength
Hits $6 and it will be a free fall like a lead balloon. Then just make sure the last one out turns off the lights before they leave the party will be over.
Close above 10 today?
I put it at a strong by at .0001 to play the bounce HARDY HAR HAR, lying only got your bogus company with fake patents, fake patent court cases so far, unloading 33 million shares was the icing on the cake. And why not just google the Company Headquarters on Google Earth pretty isn't it what do 34 cats live there. Its like the office for the headquarters of the fake company in the movie Boiler Room LOL
Financials and product offerings are looking strong. Meanwhile competitors continue bogus smear campaign. Open your eyes people! Come on!
Hey didn't read it it all the first time. lol
thanks for your help
You believe that garbage?
They just also going to be selling more shares,checkout news in Ihub
Be dismissive of your own analysis. They just won a court case against Avita for their patent. Now they can set up appropriate clinical trials for FDA approval.
Whatever its been written up that it is a scam.
From Seeking Alpha
RenovaCare: First The Promos, Now The Registration
Feb.15.18 | About: RenovaCare, Inc. (RCAR)
The Street Sweeper
The Street Sweeper
Short only, contrarian
TheStreetSweeper
(1,421 followers)
Summary
Now that the stock has risen on the heels of a promotional campaign, RenovaCare has registered to allow the sale of 4.4 million shares.
The CEO and the majority shareholder plan to sell the bulk of the stock. However, RenovaCare itself will not receive proceeds from the sale.
The 10 selling stockholders, at the recent stock price, would receive about $33 million. This windfall is courtesy of a company that paid $400K for its sole, unproven, non-FDA-approved product.
Rather than releasing a distracting statement against TheStreetSweeper's probe, RenovaCare would better serve its investors by displaying the insider selling plan in a public format such as Yahoo, Seeking Alpha, etc.
RenovaCare (OTCQB:RCAR) just issued a press release basically telling shareholders not to worry their pretty little heads over TheStreetSweeper’s ongoing probe into RenovaCare issues.
Unfortunately, RenovaCare did not tell investors the real news. So we will.
RenovaCare’s CEO and biggest owner have lined up to sell millions of shares of company stock.
That’s right. Those folks and other insiders have registered to unload 4.4 million shares of stock into RenovaCare's high market value.
It's important that shareholders understand what this really means. It means - on the backs of small investors - these insiders may cash out at over $33 million at these price levels ... on a bulletin board company that paid $400,000 for its highly promoted sole asset ... which underlies a product that is totally unproven.
We're sternly putting our foot down that the only valuable news of the day is this pending insider selling and the impact on shareholders.
We would kindly appreciate the company putting this information on Yahoo Finance and other outlets in the same aggressive manner that RenovaCare has devoted to other news releases.
This selling must not be buried in a filing.
This stock selling must be displayed for all investors to see ... in a public format ... rather than buried in SEC filings.
Fake news. They just sealed a patent, good luck telling your grandkids about this dump right? Skin grafts will be a thing of the past. Welcome to the new age of medicine.
Share price aside, RCAR and their products is a company to believe in. I wish them the best of luck.
Up 2.00. If that's the sound of timber, I could listen to it all day
TIMBERRRRRRRR I warned ya......
RenovaCare: First The Promos, Now The Registration
Summary
Now that the stock has risen on the heels of a promotional campaign, RenovaCare has registered to allow the sale of 4.4 million shares.
The CEO and the majority shareholder plan to sell the bulk of the stock. However, RenovaCare itself will not receive proceeds from the sale.
The 10 selling stockholders, at the recent stock price, would receive about $33 million. This windfall is courtesy of a company that paid $400K for its sole, unproven, non-FDA-approved product.
Rather than releasing a distracting statement against TheStreetSweeper's probe, RenovaCare would better serve its investors by displaying the insider selling plan in a public format such as Yahoo, Seeking Alpha, etc.
RenovaCare (OTCQB:RCAR) just issued a press release basically telling shareholders not to worry their pretty little heads over TheStreetSweeper’s ongoing probe into RenovaCare issues.
A fraud from creepy shady criminalistic people with a long history of such activity always Google the backgrounds of the people you are investing your hard earned money in. Back to .0001 for this dog and pony show.
Funny? filing an S-1, lol
Do some research people if you own this stock. Same crew of company officers headed a now tanked P&D company. The "same" exact photos used on websites, Google those people you will not like what you find. One was busted for stock fraud, Get on Google and check it out before the lights go out, just a friendly word of advice check for yourself.
Other company from OTC Disclosure service.....
The Biomedical Advanced Research and Development Authority (BARDA), under the Assistant Secretary for Preparedness and Response, within the US Department of Health and Human Services, continues to support the development of RECELL. In September 2017, BARDA executed a contract option valued at approximately US$24.3 million to expand the application of RECELL to a vulnerable population, children. This contract option provides funding for key clinical and health economics research in pediatric burn care and extends the period of performance of Avitas Project Bioshield contract with BARDA through September 2022.
That's the government and why one would ask would they be worried about a silly plastic gun? Its already being distributed all over the world, when FDA approves in the coming months cya. Do some DD if you got sold this stock, contact other company they will tell you they never released such a PR. It was a fake, written in horrible English. Check your companies officers backgrounds head to Goggle do some DD. IMHO you have been had, GLTA.
Renovacare is fake shell company that has been several other failed stocks previously, all run by the same person. Street view their headquarters, a dingy windowless building in New York. Attempt to contact IR, there is no one to speak to or return a call.
RenovaCare owns them. Another company from Australia wants to do the same thing. They claim you cant have a patent on such a thing.
Are these the patents in question?
seems pretty straight forward to me who owns them
Patent No. US 9,505,000 B2
Patent No. US 9,610,430 B2
RCAR patent has been challenged at the USPTO for at least a month. Why is this not a topic on this board? An Australian company has this technology and a big contract with the U.S. military already.
Renovacare has not started a clinical trial. It will be many, many years before their product could even have a chance at generating revenue. Meanwhile, Avita Medical (AVMXY) just met both primary endpoints in a Phase 3 pivotal trial and is set to commercialize Recell in early 2018 for burn care. Avita also has a $60,000,000 U.S. federal government with BARDA, and under the terms of that contract, BARDA has agreed to purchase 5,000 Recell units for $8,000,000 which could drop anytime really. Avita market cap = under 50 million. Renovacare market cap = 300 million. Renovacare U.S. share count = 75M (and doing a raise as we speak); Avita U.S. share count = 33.5M. And finally, no Typhoon, Renovacare doesn't hold the PATENTS lol. Sorry brother, Avita has much stronger patents in this space and the patent board IMO will agree as such. Renovacare in my humble opinion has peaked and is on the way down.
Watch out for investors from Avita. They are mad that RenovaCare holds the patents which makes shares from Avita useless. They are trying to fight for the rights to operate but its not looking to be in their favor. Because RenovaCare has the PATENT.
I tried contacting Renovacare several times to no avail. Just a very strange automated voice that sends you to voicemail. No one answering during business hours or returning polite inquires.
They also conducted the trial at the actual largest burn center in the U.S.. I know someone there, Renovacare is not in the building. But Avita is not related to the issue at hand. Renovacare is run and owned by a suspected pump and dump artist.
FACT: Renovacare is doing an equity raise and has YET TO START A CLINICAL TRIAL. They are light years behind Avita Medical, which by the way holds the patents in this space. Another fact to leave you with: Avita just completed a successful Phase 3 pivotal trial and is submitting the results for FDA approval as we speak. So yea, Renovacare, which is led by a guy who has previously been fined by the SEC for penny stock promotion, is in serious trouble.
This bloated equity is in some serious trouble. Avita (AVMXY) just completed a successful P3 pivotal trial with Recell, and Renovacare, which trades at 10x the market cap, has yet to start a clinical trial! Add on top of that Avita holds patents that supercede Renovacare in the space. Renovacare is about to crash and burn IMHO.
RENOVACARE is the REAL deal
I am a nurse and work in one of the largest burn units in the us and have been following renovacare for some time. This technology is truly amazing and yes it is 100% real. I have seen the results of the skingun first hand and as for the people who are badmouthing the company on this message board shame on you. If you have ever known someone that has suffered severe burns you would be helping this amazing company get traction with investors so they can quickly get their products to market through some sort of FDA fast track.
As for DD the best thing you can do is refer to prestigious medical journals, not a few people trying to hurt the stock price for their own gains. The skingun was published in the BURNS medical journal here is the links that prove this is light years ahead of what medical professionals like myself are using today. Company Press
BURNS journal
RENOVACARE is the REAL deal
I am a nurse and work in one of the largest burn units in the us and have been following renovacare for some time. This technology is truly amazing and yes it is 100% real. I have seen the results of the skingun first hand and as for the people who are badmouthing the company on this message board shame on you. If you have ever known someone that has suffered severe burns you would be helping this amazing company get traction with investors so they can quickly get their products to market through some sort of FDA fast track.
As for DD the best thing you can do is refer to prestigious medical journals, not a few people trying to hurt the stock price for their own gains. The skingun was published in the BURNS medical journal here is the links that prove this is light years ahead of what medical professionals like myself are using today. Company Press
BURNS journal
I am. I know the space, I've owned multiple wound care stocks. But I don't buy stocks run by people with very questionable backgrounds such as this. The warning signs should be obvious even to the most uneducated investor.
I'm sure you would, considering you're an investor in Renovacare's competitor.
Wow. I don't feel bad for people who buy stock without doing dd but I would suggest everyone reading this sell.
Harmel Rayat and his family-owned Kalen Capital own 66% of the stock in Renovacare! Rayat is a notorious penny stock promoter. See his history with Octillion, one of countless failed penny promotions that Rayat orchestrated.
https://seekingalpha.com/article/55907-is-octillion-really-worth-134-million
https://seekingalpha.com/article/46455-stay-away-from-octillion
http://thestreetsweeper.org/undersurveillance/SolarWindow_Technologies__After_18_Years__Still_No_Product__No_Revenue__No_Rainbow_Ahead
"Let's pull back the curtain to get a closer look at SolarWindow's great benefactor and chief creditor.
That money guy is Harmel Rayat, an entrepreneur who is particularly adept at promoting his book, speaking engagements and investment website, plus establishing leadership positions in various disappointing companies.
Mr. Rayat was ordered by the Securities and Exchange Commission in 2003 to cease and desist certain activities related to the way his now-defunct stock promotion entity, EquityAlert, pushed another company in which he held various leadership roles, Innotech. Mr. Rayat and his EquityAlert agreed to settle with a civil penalty totaling $40,000."
I believe that RenovaCare is a company of questionable background.
Did you know they were Janus Resources -symbol JANI- until 2013? An "oil and gas" company. Prior to that they were Entheos Technologies, Inc. symbol ETHT. And prior to that several others, all owned/run by this guy who is a 10%+ owner of Renovacare... https://www.investorvillage.com/mbthread.asp?mb=6741&tid=3301750&showall=1
The police officer they publicize was treated back in 2009, way before Renovacare was involved. Seems they bought the device and have been marketing it rather than doing any clinical work. I think the company exists to create trading and salaries for some.
From Renovacare S-3:
Lawsuits against us by third-parties that allege we infringe their intellectual property rights could harm our potential business and operating results.
There is considerable patent and other intellectual property activity in the industry in which we operate. We may be unaware of intellectual property rights of others that may cover some or all of our technology. Additionally, notwithstanding our receipt of a patent, a third-party may nevertheless challenge the validity of one or more claims included in the patent, which may require us to expend significant funds to defend our claims. For example, on April 4, 2017, the U.S. Patent & Trademark Office (the “ PTO ”) issued to us U.S. Patent No. 9,610, 430 related to our device and method for spraying autologous skin cells. On or about April 11, 2017, we received from Avita Medical Limited (“ Avita ”) a paper copy of what was labeled a Petition for Inter Partes Review purporting to challenge the validity of the claims in U.S. Patent No. 9,610,430 (the “ Petition ”) before the Patent Trial and Appeal Board (“PTAB ”), which is an administrative proceeding of the PTO (the “ Proceeding ”). We do not agree with the assertions set forth in the Petition and we intend to defend our intellectual property. In the event the Proceeding progresses, the PTAB may find (i) that the Petition is insufficient to establish that any such claims are unpatentable and accordingly confirm all of the claims in our U.S. Patent No. 9,610,430 or (ii) one or more claims of U.S. Patent No. 9,610,430 to be unpatentable and cancel any such claims and confirm the balance of such claims.
That's the last time I trust you.
They are not being sued. Avita claim that 430 RenovaCares patent are unpatentable and should be cancelled. Their system looks generic. So I would not be scared one way or another.
Lawsuit Against Renovacare hey boys, just wanna let you know Avita Medical [AVMXY] has filed a lawsuit against Renovacare for patent infringement. I guess Renovacare will tell you when they get around to it. Avita has notified its shareholders. Good luck!
https://www.insiderfinancial.com/renovacare-inc-otcmktsrcar-is-a-sleeping-giant/122566/
Also notable is the fact that the data referenced above resulted in a shift to using the technology as a standard care therapy in the University Hospital in which he was being tested. The following is a quote taken from RenovaCare’s latest filing:
“The same researchers concluded that, “We refuse to perform a prospective randomized study with groups in which traditional skin grafting and/or wound healing are still applied for the therapy for deep dermal burns due to the excellent results in our study. The method of CEA spray application has become our standard of care for these indications. The faster wound closure, the promotion of spontaneous wound healing by keratinocyte application, as well as the preservation of donor sites are further advantages of the method.”
This stock is going to be huge pretty soon!
http://www.businesswire.com/news/home/20170427005365/en/Outcomes-Burn-Patients-Treated-Cell-Spray-Technology
We need to be patient. They have shown amazing results, but now need to go through Clinical and pre-Clinicals to prove to the FDA the efficacy of their technology. Then, they apply for right to Market the technology. We'll likely see some bumps up in price as more coverage takes place, but its usage as an approved treatment and thus revenue are a ways off yet. But, count me in - I'm in accumulation mode.
Followers
|
11
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
218
|
Created
|
09/05/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |